Genomma Lab Internacional S.A.B. de C.V

Research Genomma Lab Internacional S.A.B. de C.V (GEKA) on Bullrun: valuation model: 30.3% undervalued, market cap EUR 708.87M, P/E 9.1, dividend yield 5.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGEKA
• ExchangeF
• CountryMexico
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Valuation signal30.3% undervalued
• Market capEUR 708.87M
• P/E9.1
• Dividend yield5.5%
• Financial periodQ1 2026
• RevenueEUR 4.19B
• Net incomeEUR 494.65M
• Free cash flow-EUR 344.44M
• Gross margin63.4%

Valuation Snapshot

Bullrun's latest valuation model marks Genomma Lab Internacional S.A.B. de C.V as 30.3% undervalued; latest market cap is EUR 708.87M; P/E is 9.1; dividend yield is 5.5%.

About Genomma Lab Internacional S.A.B. de C.V

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally.

Frequently asked questions

Is Genomma Lab Internacional S.A.B. de C.V overvalued or undervalued?

Bullrun's valuation model currently marks Genomma Lab Internacional S.A.B. de C.V as 30.3% undervalued.

What is Genomma Lab Internacional S.A.B. de C.V's market cap?

Genomma Lab Internacional S.A.B. de C.V's market capitalization is EUR 708.87M.

What is Genomma Lab Internacional S.A.B. de C.V's P/E ratio?

Genomma Lab Internacional S.A.B. de C.V's price-to-earnings (P/E) ratio is 9.1.

Does Genomma Lab Internacional S.A.B. de C.V pay a dividend?

Genomma Lab Internacional S.A.B. de C.V has a dividend yield of 5.5%.

What does Genomma Lab Internacional S.A.B. de C.V do?

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally.